AutoICD API

E77.1

Billable

Defects in glycoprotein degradation

Defects in glycoprotein degradation

Status

Billable / Specific

Block

E70-E88

Parent Code

E77

ICD-11 Mapping

1 equivalent

Coding Notes

Inclusion Terms

Alternative clinical terms for this condition

  • Aspartylglucosaminuria
  • Fucosidosis
  • Mannosidosis
  • Sialidosis [mucolipidosis I]

Excludes 1

Codes that cannot be used together with this code (mutual exclusion)

Excludes 2

Conditions not included here, but the patient may have both

Related Codes(3)
E77.0

Defects in post-translational mod of lysosomal enzymes

BillableE77.8

Other disorders of glycoprotein metabolism

BillableE77.9

Disorder of glycoprotein metabolism, unspecified

Billable
ICD-11 Equivalents(1)

ICD-11 Equivalents

View full mapping

Corresponding ICD-11 codes from the WHO crosswalk mapping

5C56.4Disorders of sialic acid metabolismequivalentPrimary
Also Known As / Clinical Terms(304)

SNOMED CT

UMLS

Clinical Terms

  • alpha-L-fucosidase deficiency
  • Deficiency Syndrome, Mannosidase
  • mucolipidosis I
  • Mucolipidosis Type 1
  • Alpha-Fucosidase Deficiency
  • Neuraminidase deficiency with beta-galactosidase deficiency
  • Disease, alpha-Fucosidase Deficiency
  • Juvenile mannosidosis
  • alpha-Fucosidase Deficiency Disease
  • Mannosidosis, type I
  • Type I Mucolipidosis
  • Deficiency, Glycoprotein Neuraminidase
  • Nephrosialidosis
  • Infantile mannosidosis
  • Glycoasparaginase Deficiency
  • ASPARTYLGLUCOSAMINIDASE DEFICIENCY
  • DEFIC DIS ALPHA FUCOSIDASE
  • Combined deficiency of neuroaminidase and beta galactosidase
  • ASPARTYLGLYCOSAMINURIA
  • Deficiencies, AGA
  • Fucosidosis
  • sialidosis
  • Fucosidosis, type II
  • AGA Deficiency
  • Aspartylglucosaminuria
  • Diseases, alpha-L-Fucosidase Deficiency
  • Normomorphic sialidosis
  • Deficiency Disease, Mannosidase
  • Diseases, alpha-Fucosidase Deficiency
  • Myoclonus cherry red spot syndrome
  • Deficiency Diseases, Fucosidase
  • GLYCOASPARAGINASE
  • Combined deficiency of sialidase AND beta galactosidase
  • MYOCLONUS--CHERRY RED SPOT SYNDROME
  • mannosidase deficiency
  • Protective protein deficiency
  • Goldberg syndrome
  • Cherry red spot myoclonus syndrome
  • Deficiency Disease, Fucosidase
  • Type I Mucolipidoses
  • Mannosidase Deficiency Syndrome
  • sialidoses
  • Mannosidosis, juvenile-adult onset
  • AGA Deficiencies
  • Aspartylglycosaminurias
  • Mannosidoses
  • Cherry Red Spot-Myoclonus Syndrome
  • Mannosidase Deficiency Disease
  • Sialidosis type 1
  • Deficiency Diseases, Mannosidase
  • Beta-mannosidase deficiency
  • Deficiency Disease, alpha-L-Fucosidase
  • Galactosialidosis
  • Mucolipidosis
  • alpha-Fucosidase Deficiency Diseases
  • alpha-Mannosidase deficiency
  • Deficiency Diseases, alpha-Fucosidase
  • AGU
  • Glycoprotein Neuraminidase Deficiencies
  • Fucosidase Deficiency Diseases
  • Sialidosis, type 2
  • MANNOSIDASE DEFIC DIS
  • Deficiencies, Glycoasparaginase
  • alpha-L-Fucosidase Deficiency Diseases
  • Deficiency, Glycoasparaginase
  • alpha-L-Fucosidase Deficiency Disease
  • Dysmorphic sialidosis, congenital form
  • Aspartylglucosaminurias
  • Fucosidosis type II
  • Neuroaminidase deficiency
  • Disease, Fucosidase Deficiency
  • Mucolipidoses, Type I
  • Neuraminidase deficiency
  • Myoclonic disorder due to sialidosis
  • Fucosidase Deficiency Disease
  • Mucolipidosis, Type I
  • MANNOSIDASE DEFIC SYNDROMES
  • Fucosidosis, juvenile form
  • Dysmorphic sialidosis, juvenile form
  • Mucolipidosis type I
  • GSL - Galactosialidosis
  • Disease, alpha-L-Fucosidase Deficiency
  • alpha Fucosidase Deficiency Disease
  • Fucosidosis, fatal infantile type
  • ALPHA L FUCOSIDASE DEFIC DIS
  • ALPHA FUCOSIDASE DEFIC DIS
  • Diseases, Mannosidase Deficiency
  • Deficiencies, Glycoprotein Neuraminidase
  • Myoclonus-Cherry Red Spot Syndrome
  • Deficiency Disease, alpha-Fucosidase
  • Infantile fucosidosis
  • Mannosidosis, type II
  • Mannosidase Deficiency Diseases
  • DEFIC DIS ALPHA L FUCOSIDASE
  • Sialidase deficiency
  • Mannosidosis (disorder)
  • Sialidosis Type II
  • Fucosidase deficiency
  • Juvenile fucosidosis
  • Fucosidosis (disorder)
  • Deficiency Disease, alpha L Fucosidase
  • Dysmorphic sialidosis with renal involvement
  • Beta-D-mannosidosis
  • mannosidosis
  • Childhood fucosidosis
  • Mannosidosis, severe form
  • Aspartylglucosamidase Deficiency
  • Deficiency Diseases, alpha-L-Fucosidase
  • Glycoprotein Neuraminidase Deficiency
  • Aspartylglucosamidase Deficiencies
  • Adult fucosidosis
  • Fucosidosis, type I
  • Mannosidosis, mild form
  • alpha fucosidase deficiency
  • Alpha-D-mannosidosis
  • Sialidosis [mucolipidosis I]
  • CHERRY RED SPOT--MYOCLONUS SYNDROME
  • Oligosaccharidosis
  • Sialidosis (disorder)
  • alpha L Fucosidase Deficiency Disease
  • Glycoasparaginase Deficiencies
  • Deficiency, Aspartylglucosamidase
  • Deficiencies, Aspartylglucosamidase
  • Deficiency Disease, alpha Fucosidase
  • Aspartylglucosaminuria (disorder)
  • Mannosidosis infantile onset
  • Diseases, Fucosidase Deficiency
  • Lipomucopolysaccharidosis
  • Deficiency, AGA
  • Mannosidase Deficiency Syndromes
  • Dysmorphic sialidosis
  • Fucosidosis type I
  • Deficiency Syndromes, Mannosidase
  • Dysmorphic sialidosis, infantile form
  • FUCOSIDASE DEFIC DIS
Frequently Asked Questions
What is the ICD-10 code for defects in glycoprotein degradation?

The ICD-10-CM code for defects in glycoprotein degradation is E77.1. The full clinical description is "Defects in glycoprotein degradation". E77.1 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code E77.1 mean?

ICD-10-CM code E77.1 represents “Defects in glycoprotein degradation”. It is classified under Chapter 4: Endocrine, Nutritional and Metabolic Diseases and is a billable/specific code that can be used on a claim.

Is E77.1 a billable code?

Yes, E77.1 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is E77.1 in?

E77.1 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).

What codes cannot be used with E77.1?

E77.1 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); and 3 more.

What SNOMED CT codes does E77.1 map to?

E77.1 maps to 20 SNOMED CT concepts: 399249008, 65524005, 64716005, 54954004, 238047006, and 15 more. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for E77.1?

E77.1 is linked to 5 UMLS Concept Unique Identifiers: C0268225, C0016788, C0268226, C0494342, C1257960. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

How does E77.1 relate to ICF functioning codes?

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like defects in glycoprotein degradation affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

What is the ICD-11 equivalent of E77.1?

E77.1 maps to the ICD-11 code: 5C56.4 (Disorders of sialic acid metabolism).

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Try FreeView API Docs

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.